Abstract:Background: Vascular fibrosis is linked with many diseases, including hypertension. Upon pathophysiological stimulation, fibroblasts undergo phenotypic switch and increase extracellular matrix (ECM) synthesis and deposition. Wnt1-inducible signalling pathway protein 1 (WISP-1) is a growth factor implicated in fibrotic remodelling. We tested the hypothesis that WISP-1 induces cardiac fibroblast activation and increases ECM deposition, thereby contributing to vascular fibrosis in hypertension. Methods and Results: Primary human cardiac fibroblasts (HCFs) were treated with recombinant WISP-1. Western blotting analysis showed that WISP-1 treatment for 30 minutes activated Akt pathway (phospho-Akt:total-Akt, fold change: 1.33±0.14 vs. 1.00±0, n=9, P <0.05). WISP-1 induced Akt phosphorylation was inhibited by an integrin β1 blocking antibody (phospho-Akt:total-Akt, fold change, 0.52±0.12 vs. 1.00±0, n=5, P <0.05). WISP-1 treatment for 24 hours induced collagen 1 maturation in conditioned media and coincided with decreased meprin α metalloproteinase protein levels (fold change: 0.44±0.14 vs. 1.00±0, n=5, P <0.05). The collagen maturation was inhibited by a zinc-mediated proteinase inhibitor (GM6001) or an Akt inhibitor. Additionally, immunocytochemistry analysis illustrated that 24-hour WISP-1 treatment increased the percentage of α-smooth muscle actin-positive HCFs compared to the control (1.89±0.37 vs. 1.00±0, n=8, P <0.05). In vivo , WISP-1 knockout mice exhibited reduced collagen 1 content (0.39±0.09 vs. 1.19±0.25, n=5-7, P <0.05) and proteoglycan content (2.20±0.37 vs. 6.22±1.10, n=5-7, P <0.05,) in the perivascular area compared to their wild-type control after 28 days angiotensin II (1000ng/kg/min) infusion. Conclusions: WISP-1 activates cardiac fibroblasts via integrin β1-Akt pathway and meprin α metalloproteinase, thereby inducing fibroblast phenotypic switch and promoting collagen deposition. Deletion of WISP-1 alleviated hypertension induced vascular fibrosis in vivo . Modulation of WISP-1 levels may be beneficial for attenuating the effects of hypertension on vascular fibrosis, and could provide potential therapeutic targets in clinical treatment.

Inhibition of Fibroblast Growth by Notch1 Signaling is Mediated by Induction of Wnt11-Dependent Wisp-1

Stage-specific Effects of Notch Activation During Skeletal Myogenesis

Notch1 signaling determines the plasticity and function of fibroblasts in diabetic wounds

Inhibition of Endothelial Cell Proliferation by Notch1 Signaling is Mediated by Repressing MAPK and PI3K/Akt Pathways and Requires MAML1

Notch Signaling Inhibits Cardiac Fibroblast To Myofibroblast Transformation By Antagonizing Tgf-Beta 1/Smad3 Signaling

Retraction Notice to “Notch-1 Induces Epithelial-mesenchymal Transition Consistent with Cancer Stem Cell Phenotype in Pancreatic Cancer Cells”

Down-regulation of Notch-1 Contributes to Cell Growth Inhibition and Apoptosis in Pancreatic Cancer Cells

Abstract P3127: Wnt1-inducible Signalling Pathway Protein 1 Contributes To Vascular Fibrosis By Promoting Fibroblasts Phenotypic Switch And Extracellular Matrix Deposition

Notch1 is involved in migration and invasion of human breast cancer cells.

Inhibition of Notch Intracellular Domain Suppresses Cell Activation and Fibrotic Factors Production in Hypertrophic Scar Fibroblasts Versus Normal Skin Fibroblasts.

WISP-1 Regulates Cardiac Fibrosis by Promoting Cardiac Fibroblasts' Activation and Collagen Processing

Feedback Activation of Basic Fibroblast Growth Factor Signaling via the Wnt/β-Catenin Pathway in Skin Fibroblasts

Disruption of Myofibroblastic Notch Signaling Attenuates Liver Fibrosis by Modulating Fibrosis Progression and Regression.

Epithelial and interstitial Notch1 activity contributes to the myofibroblastic phenotype and fibrosis

Notch3 Modulates Cardiac Fibroblast Proliferation, Apoptosis, and Fibroblast to Myofibroblast Transition via Negative Regulation of the RhoA/ROCK/Hif1α Axis

HuR-dependent expression of Wisp1 is necessary for TGFβ-induced cardiac myofibroblast activity

WNT1‐inducible‐signaling Pathway Protein 1 Regulates the Development of Kidney Fibrosis Through the TGF‐β1 Pathway

The interplay of the Notch signaling in hepatic stellate cells and macrophages determines the fate of liver fibrogenesis

Role of WISP1 in Stellate Cell Migration and Liver Fibrosis

Stage-Dependent Fibrotic Gene Profiling of WISP1-Mediated Fibrogenesis in Human Fibroblasts

Notch signaling regulates pulmonary fibrosis